Endo Phamaceuticals Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Endo Phamaceuticals Inc.

Sort by

Viewing results 1‒25 of 68

Special ReportJapan and Sustainability
Care homes in Japan use big data to boost caregivers and lighten workloads
...Ken Endo, the chief executive of Sompo’s nursing care and seniors business, says “the industry is 100 per cent dependent on people, yet there has been no system in place to deepen your expertise” — a fact...
July 2, 2023
Inside BusinessKana Inagaki
Mizuho’s tech woes point to a legacy of unresolved issues from merger
...“In Japan, vendors supply about 70 per cent of the IT engineers and the ratio of IT specialists inside the banks is extremely low,” said Endo....
September 28, 2021
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
US opioid epidemic
US states near $26bn opioid settlement with J&J, drug distributors
...Its case against Endo, Teva, and Allergan is currently being tried in state court. The settlement payments to New York will begin this summer and continue over the next 17 years....
July 20, 2021
US opioid epidemic
J&J to pay $230m to settle New York state opioid case
...In addition to J&J, the complaint named Purdue Pharma and the members of the Sackler family that own it, Mallinckrodt, Endo, and Teva among others....
June 26, 2021
FT CollectionsGreensill Capital
Tokio Marine defends governance over Greensill exposure
...“We plan to continue investigating the validity of the insurance policies,” Endo said....
May 20, 2021
News in-depthNikkei Asia
China goes on an intellectual property offensive
...This will increase the merits of filing patent infringement suits, according to lawyer Makoto Endo....
September 26, 2021
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
News in-depthNikkei Asia
Japan cries ‘Help wanted’ but few foreigners heed the call Premium content
.... ©2019 Nikkei Inc. All rights reserved....
October 22, 2019
Financial Services Agency Japan
Japanese financial regulator unveils shake-up for stock exchange
...“What we want from companies, and what investors expect, is effective governance,” said Mr Endo....
November 28, 2019
US opioid epidemic
J&J verdict hits share prices across opioid industry
...This month, Endo announced it had settled in principle by agreeing to pay $10m and up to $1m in products to two plaintiff counties in Ohio....
August 27, 2019
US opioid epidemic
US opioid trial to go ahead after settlement talks fail
...Endo International, which settled these cases for about $10m, was down 2.4 per cent to $4.76, and Mallinckrodt, which settled the two cases for about $30m, fell 3 per cent to $2.66....
October 18, 2019
Due Diligence
Lekoil scam: a lesson in due diligence Premium content
...Japan Inc: corporate governance battle The stage is set for a rare hostile takeover drama in Japan as Yoshiaki Murakami (below) –– the country’s most notorious shareholder activist –– sets his eyes on a...
January 21, 2020
FT Magazine
Opioids, bribery and Wall Street: the inside story of a disgraced drugmaker
...It has requested that one opioid — Opana ER, made by Endo Pharmaceuticals — be removed from the market because of patterns of abuse, but also approved Dsuvia, by AcelRx Pharmaceuticals, another fast-acting...
June 19, 2020
FTfm
Nissan’s parable of shoddy governance
...The carmaker “had literally no governance structure”, Koji Endo, head of the equity research department at SBI Securities, said at the time of the arrest in November....
May 13, 2019
News in-depthNikkei Asia
Empty golf links highlight charm and despair of remote rural Japan Premium content
...A version of this article was first published by the Nikkei Asian Review on May 5 2019. ©2019 Nikkei Inc. All rights reserved....
May 12, 2019
News in-depthThe Big Read
US seeks a fix for its opioid addiction
...Among the most commonly named defendants are drugmakers such as Purdue Pharmaceuticals, which is privately owned, Johnson & Johnson, Allergan, Mallinckrodt, Endo and Teva; distributors such as McKesson,...
September 11, 2017
FT Live
Global Private Banking Awards 2024
Celebrating excellence in wealth management
Thursday, 7 NovemberThe Landmark London, London, UK
News in-depthWeek in Review
Week in review, December 16
...The new system would probably be funded by the pharmaceutical groups that manufacture opioid medicines — such as Perdue Pharma, Endo and Depomed — which have been sharply criticised for fuelling the crisis...
December 15, 2017
US equities
Drugmaker Endo rises on leadership change
...Shares in Endo rose 15.5 per cent to $23.39 in New York after the company said Rajiv De Silva, who has served at the helm since March 2014 and helped grow Endo’s overseas presence, was stepping down....
September 23, 2016
World
Duterte has three words on infrastructure: ‘Build, Build, Build’ Premium content
...Nikkei staff writer Jun Endo contributed to this report. A version of this article was first published by the Nikkei Asian Review on January 23. ©2018 Nikkei Inc. All rights reserved....
January 28, 2018
US & Canadian companies
FTC sues Endo over ‘pay for delay’ deals
...Some investors argue that Endo is similarly overly-reliant on debt-fuelled deal making and high drug prices....
March 31, 2016
Japanese business & finance
Japan rallies to defend Toyota after Trump warning
...Japanese government officials pushed back against Donald Trump’s criticism of Toyota as the attack on the country’s most powerful corporate name sent shockwaves across Japan Inc....
January 6, 2017
High yield bonds
Music shifts for credit investors in 2015
...Fears surrounding Valeant reverberated through to other junk-rated healthcare companies, including Endo International and Mallinckrodt....
December 30, 2015
High yield bonds
Healthcare junk bonds sting investors
...The three companies — Valeant, Endo and Mallinckrodt — have levered up over the past two years in aggressive expansions....
October 1, 2015
Inside BusinessJonathan Ford
Valeant is the latest troubled roll-up to unravel
...Valeant, for instance, ended up going toe to toe with another roll-up, Endo, in the bidding war for Salix. But most platform companies ultimately unwind because they depend excessively on momentum....
March 20, 2016
LexUS & Canadian companies
Endo/Par: too much of a good thing
...Why, then, is the market so tepid on Endo’s $8bn cash and stock purchase of Par, a generics company? After Monday’s announcement, Endo’s shares fell 5 per cent....
May 18, 2015
The FT ViewPharmaceuticals sector
Shkreli and the true cost of high drug prices
...A number of listed pharmaceutical companies, including Valeant, Endo and Mallinckrodt, have made it their business to buy up branded off-patent remedies and pump up prices....
December 22, 2015

Previous pagePage 1 of 3Next page